T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$1.09T
| $1.17B | 0.25% |
14,901,905
-1,324,348
| -8% | -$99.7M |
|
102
Abbott
ABT
$189B
| $1.16B | 0.25% |
29,518,377
+6,213,260
| +27% | +$247M |
|
103
MetLife
MET
$61.4B
| $1.15B | 0.24% |
32,476,168
-7,258,062
| -18% | -$283M |
|
104
Simon Property Group
SPG
$71.8B
| $1.14B | 0.24% |
5,249,792
-76,467
| -1% | -$15.6M |
|
105
Occidental Petroleum
OXY
$59.5B
| $1.14B | 0.24% |
15,033,831
+1,795,839
| +14% | +$134M |
|
106
Chevron
CVX
$387B
| $1.12B | 0.24% |
10,655,858
-905,305
| -8% | -$91.1M |
|
107
Norwegian Cruise Line
NCLH
$8.56B
| $1.11B | 0.24% |
27,905,730
+3,153,447
| +13% | +$150M |
|
108
L3Harris
LHX
$53.3B
| $1.1B | 0.23% |
13,126,399
+5,192,425
| +65% | +$410M |
|
109
Merck
MRK
$321B
| $1.09B | 0.23% |
19,810,814
+1,197,933
| +6% | +$63.8M |
|
110
Walmart Inc
WMT
$896B
| $1.09B | 0.23% |
44,677,239
+1,950,381
| +5% | +$45.1M |
|
111
Ross Stores
ROST
$80.8B
| $1.08B | 0.23% |
19,058,860
+1,601,373
| +9% | +$88.9M |
|
|
DD
112
DELISTED
Du Pont De Nemours E I
DD
| $1.08B | 0.23% |
16,629,948
+93,155
| +0.6% | +$6.12M |
|
|
WCN
113
Waste Connections
WCN
$42.1B
| $1.02B | 0.22% |
21,281,535
-459,153
| -2% | -$20.9M |
|
114
Royal Caribbean
RCL
$81.5B
| $1.02B | 0.22% |
15,207,495
-6,282
| -0% | -$481K |
|
115
Weyerhaeuser
WY
$18B
| $1.02B | 0.22% |
34,198,186
-2,186,537
| -6% | -$67.2M |
|
116
Baidu
BIDU
$35.9B
| $1.01B | 0.21% |
6,126,040
-777,746
| -11% | -$137M |
|
117
AES
AES
$10.5B
| $1.01B | 0.21% |
81,041,549
-11,933,078
| -13% | -$134M |
|
|
IHS
118
DELISTED
IHS INC CL-A COM STK
IHS
| $1.01B | 0.21% |
8,740,831
+661,264
| +8% | +$79.4M |
|
119
Las Vegas Sands
LVS
$29.6B
| $996M | 0.21% |
22,907,052
-251,631
| -1% | -$11.8M |
|
120
Pentair
PNR
$10.6B
| $990M | 0.21% |
25,300,123
-2,507,061
| -9% | -$97.5M |
|
121
Costco
COST
$418B
| $986M | 0.21% |
6,281,057
+2,327,680
| +59% | +$352M |
|
122
Incyte
INCY
$24.5B
| $984M | 0.21% |
12,297,287
-3,837,965
| -24% | -$298M |
|
123
Loews
L
$23.1B
| $975M | 0.21% |
23,739,228
+857,525
| +4% | +$34M |
|
124
Blackrock
BLK
$177B
| $967M | 0.2% |
2,821,933
+213,852
| +8% | +$75.1M |
|
125
ASML
ASML
$689B
| $953M | 0.2% |
9,604,273
+2,048,332
| +27% | +$199M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.